How should proteinuria be detected and measured?

被引:190
作者
Lamb, Edmund J. [1 ]
MacKenzie, Finlay [3 ]
Stevens, Paul E. [2 ]
机构
[1] Kent & Canterbury Hosp, E Kent Hosp Univ NHS Fdn Trust, Dept Clin Biochem, Canterbury CT1 3NG, Kent, England
[2] E Kent Hosp Univ NHS Fdn Trust, Dept Renal Med, Canterbury CT1 3NG, Kent, England
[3] Wolfson EQA Lab, Birmingham B15 2UE, W Midlands, England
关键词
CHRONIC KIDNEY-DISEASE; COOMASSIE BRILLIANT BLUE; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; BLOOD-PRESSURE CONTROL; CREATININE RATIO; CARDIOVASCULAR RISK; CEREBROSPINAL-FLUID; HYPERTENSIVE DISORDERS; DIPSTICK PROTEINURIA;
D O I
10.1258/acb.2009.009007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Proteinuria is a classic sign of kidney disease and its presence carries powerful prognostic information. Although proteinuria testing is enshrined in clinical practice guidelines, there is surprising variation among such guidelines as to the definition of clinically significant proteinuria. There is also poor agreement as to whether proteinuria should be defined in terms of albumin or total protein loss, with a different approach being used to stratify diabetic and non-diabetic nephropathy. Further, the role of reagent strip devices in the detection and assessment of proteinuria is unclear. This review explores these issues in relation to recent national and international guidelines on chronic kidney disease (CKD) and epidemiological evidence linking proteinuria and clinical outcome. The authors argue that use of urinary albumin measurement as the front-line test for proteinuria detection offers the best chance of improving the sensitivity, quality and consistency of approach to the early detection and management of CKD.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 106 条
[31]  
*DEP HLTH NAT SERV, 2005, PART 2 CHRON KIDN DI
[32]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[33]   Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension The Nordic Diltiazem Study [J].
Farbom, Patrik ;
Wahlstrand, Bjorn ;
Almgren, Peter ;
Skrtic, Stanko ;
Lanke, Jan ;
Weiss, Lars ;
Kjeldsen, Sverre ;
Hedner, Thomas ;
Melander, Olle .
HYPERTENSION, 2008, 52 (01) :115-122
[34]   MICROALBUMINURIA IN DIABETES - A POPULATION STUDY OF THE PREVALENCE AND AN ASSESSMENT OF 3 SCREENING-TESTS [J].
GATLING, W ;
KNIGHT, C ;
MULLEE, MA ;
HILL, RD .
DIABETIC MEDICINE, 1988, 5 (04) :343-347
[35]   USE OF SINGLE VOIDED URINE SAMPLES TO ESTIMATE QUANTITATIVE PROTEINURIA [J].
GINSBERG, JM ;
CHANG, BS ;
MATARESE, RA ;
GARELLA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (25) :1543-1546
[36]  
GOREN MP, 1986, CLIN CHEM, V32, P386
[37]  
GOSLING P, 2008, CLIN BIOCH METABOLIC, P156
[38]  
GRAZIANI MS, 2009, NEPHROL DIA IN PRESS
[39]   Diabetic nephropathy: Diagnosis, prevention, and treatment [J].
Gross, JL ;
de Azevedo, MJ ;
Silveiro, SP ;
Canani, LH ;
Caramori, ML ;
Zelmanovitz, T .
DIABETES CARE, 2005, 28 (01) :164-176
[40]  
GUY M, 2009, NEPRHROL DI IN PRESS